Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Morse

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
NMR in Biomedicine|May 24, 2011
Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agentsGary V Martinez, Xiaomeng Zhang, María L García-Martín, et al.
Bioconjugate Chemistry|October 22, 2015
Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In VivoAllison S Cohen, Renata Patek, Steven A Enkemann, et al.
Cancer Research|May 25, 2017
The Damaging Effect of Passenger Mutations on Cancer ProgressionChristopher D McFarland, Julia A Yaglom, Jonathan W Wojtkowiak, et al.
Bioconjugate Chemistry|November 3, 2012
Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligandNarges K Tafreshi, Xuan Huang, Valerie E Moberg, et al.
NMR in Biomedicine|November 20, 2008
Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathwayDavid L Morse, Danielle Carroll, Sam Day, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2010
Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptorsLiping Xu, Josef Vagner, Ramesh Alleti, et al.
Organic Letters|May 19, 2009
Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imagingJatinder S Josan, David L Morse, Liping Xu, et al.
Theranostics|March 30, 2016
Preliminary Therapy Evaluation of (225)Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from (225)Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor VisualizationDarpan N Pandya, Roy Hantgan, Mikalai M Budzevich, et al.
Journal of Surgical Oncology|February 22, 2011
The promise of nanotechnology for solving clinical problems in breast cancerStephen R Grobmyer, David L Morse, Bradley Fletcher, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Heterobivalent ligands target cell-surface receptor combinations in vivoLiping Xu, Jatinder S Josan, Josef Vagner, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
NMR in Biomedicine|May 24, 2011
Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agentsGary V Martinez, Xiaomeng Zhang, María L García-Martín, et al.
Bioconjugate Chemistry|October 22, 2015
Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In VivoAllison S Cohen, Renata Patek, Steven A Enkemann, et al.
Cancer Research|May 25, 2017
The Damaging Effect of Passenger Mutations on Cancer ProgressionChristopher D McFarland, Julia A Yaglom, Jonathan W Wojtkowiak, et al.
Bioconjugate Chemistry|November 3, 2012
Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligandNarges K Tafreshi, Xuan Huang, Valerie E Moberg, et al.
NMR in Biomedicine|November 20, 2008
Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathwayDavid L Morse, Danielle Carroll, Sam Day, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2010
Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptorsLiping Xu, Josef Vagner, Ramesh Alleti, et al.
Organic Letters|May 19, 2009
Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imagingJatinder S Josan, David L Morse, Liping Xu, et al.
Theranostics|March 30, 2016
Preliminary Therapy Evaluation of (225)Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from (225)Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor VisualizationDarpan N Pandya, Roy Hantgan, Mikalai M Budzevich, et al.
Journal of Surgical Oncology|February 22, 2011
The promise of nanotechnology for solving clinical problems in breast cancerStephen R Grobmyer, David L Morse, Bradley Fletcher, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Heterobivalent ligands target cell-surface receptor combinations in vivoLiping Xu, Jatinder S Josan, Josef Vagner, et al.
Pageof 6